Sarepta Therapeutics
SRPT
#1549
Rank
NZ$19.71 B
Marketcap
$206.41
Share price
-1.03%
Change (1 day)
4.33%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Market capitalization of Sarepta Therapeutics (SRPT)

Market cap: NZ$19.71 Billion

As of January 2025 Sarepta Therapeutics has a market cap of NZ$19.71 Billion. This makes Sarepta Therapeutics the world's 1549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sarepta Therapeutics from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$19.71 B-4.19%
2024NZ$20.57 B44.27%
2023NZ$14.26 B-20.38%
2022NZ$17.91 B56.06%
2021NZ$11.47 B-38.43%
2020NZ$18.64 B29.44%
2019NZ$14.40 B24.58%
2018NZ$11.56 B128.36%
2017NZ$5.06 B134.23%
2016NZ$2.16 B-15.95%
2015NZ$2.57 B237.13%
2014NZ$0.76 B-18.47%
2013NZ$0.93 B-5.88%
2012NZ$0.99 B667.36%
2011NZ$0.12 B-58.03%
2010NZ$0.30 B39%
2009NZ$0.22 B175.27%
2008NZ$80.68 M-31.99%
2007NZ$0.11 B-50.58%
2006NZ$0.24 B-7.08%
2005NZ$0.25 B117.04%
2004NZ$0.11 B-44.84%
2003NZ$0.21 B-14.97%
2002NZ$0.25 B-58.44%
2001NZ$0.61 B164.9%
2000NZ$0.23 B36.46%
1999NZ$0.16 B66.78%
1998NZ$0.10 B-22.45%
1997NZ$0.13 B

End of Day market cap according to different sources

On Jan 21st, 2025 the market cap of Sarepta Therapeutics was reported to be:

NZ$19.71 Billion
by Nasdaq info icon info icon
NZ$19.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$204.75 B 938.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.49 B-87.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.50 B-67.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.78 B-85.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$60.40 B 206.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.16 B-68.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.26 B 23.08%๐Ÿ‡บ๐Ÿ‡ธ USA